img width="800" height="318" title="Figure 1. Forest plots showing the SNP-specific and overall Mendelian randomization estimates for associations of genetically mimicking NK3R antagonists (based on rs116646027 and rs1351623, TACR3) with ischemic heart disease in men and the negative control outcome (ischemic heart disease in women) and the positive control outcomes in men (relative age voice broke, hypertension, prostate cancer and number of children fathered in men) per standard deviation lower testosterone in men from the UK Biobank and the PRACTICAL consortium (prostate cancer). Credit: eBioMedicine (2022). DOI: 10.1016/j.ebiom.2022.103901" alt="Genetic validation of a new means of protecting men against cardiovascular disease" src="/Editor/ebioueditorasp/asp/upload/image/20220311/16469631008762632.jpg"图1所示,显示基因模仿NK3R拮抗剂的snp特异性和整体孟德尔随机化估计(基于rs116646027和rs1351623,男性的缺血性心脏病阴性对照结果(女性的缺血性心脏病)和男性的阳性对照结果(相对年龄嗓音破裂、高血压,每一标准偏差会降低男性的睾酮水平。)